| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.47 | 6e-41 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.41 | 2e-32 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.34 | 1e-25 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-18 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.42 | 1e-16 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.28 | 7e-16 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-13 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-13 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.26 | 7e-13 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |